Active, Not Recruiting
Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC
NCT06569420
- Conditions
- ALK-positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, China